BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 18259774)

  • 1. Murine cytomegalovirus regulation of NKG2D ligands.
    Lenac T; Arapović J; Traven L; Krmpotić A; Jonjić S
    Med Microbiol Immunol; 2008 Jun; 197(2):159-66. PubMed ID: 18259774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines.
    Hiršl L; Brizić I; Jenuš T; Juranić Lisnić V; Reichel JJ; Jurković S; Krmpotić A; Jonjić S
    Front Immunol; 2018; 9():991. PubMed ID: 29867968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions.
    Lodoen MB; Abenes G; Umamoto S; Houchins JP; Liu F; Lanier LL
    J Exp Med; 2004 Oct; 200(8):1075-81. PubMed ID: 15477345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.
    Lodoen M; Ogasawara K; Hamerman JA; Arase H; Houchins JP; Mocarski ES; Lanier LL
    J Exp Med; 2003 May; 197(10):1245-53. PubMed ID: 12756263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.
    Slavuljica I; Busche A; Babić M; Mitrović M; Gašparović I; Cekinović D; Markova Car E; Pernjak Pugel E; Ciković A; Lisnić VJ; Britt WJ; Koszinowski U; Messerle M; Krmpotić A; Jonjić S
    J Clin Invest; 2010 Dec; 120(12):4532-45. PubMed ID: 21099111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ.
    Galitska G; Coscia A; Forni D; Steinbrueck L; De Meo S; Biolatti M; De Andrea M; Cagliani R; Leone A; Bertino E; Schulz T; Santoni A; Landolfo S; Sironi M; Cerboni C; Dell'Oste V
    Front Immunol; 2021; 12():532484. PubMed ID: 33897679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MCMV avoidance of recognition and control by NK cells.
    Brizić I; Lenac Roviš T; Krmpotić A; Jonjić S
    Semin Immunopathol; 2014 Nov; 36(6):641-50. PubMed ID: 25141793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NKG2D stimulation of CD8
    Kavazović I; Lenartić M; Jelenčić V; Jurković S; Lemmermann NAW; Jonjić S; Polić B; Wensveen FM
    Eur J Immunol; 2017 Jul; 47(7):1123-1135. PubMed ID: 28378389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse Cytomegalovirus m153 Protein Stabilizes Expression of the Inhibitory NKR-P1B Ligand Clr-b.
    Aguilar OA; Sampaio IS; Rahim MMA; Samaniego JD; Tilahun ME; Krishnamoorthy M; Popović B; Babić M; Krmpotić A; Treanor B; Margulies DH; Allan DSJ; Makrigiannis AP; Jonjić S; Carlyle JR
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo.
    Krmpotić A; Busch DH; Bubić I; Gebhardt F; Hengel H; Hasan M; Scalzo AA; Koszinowski UH; Jonjić S
    Nat Immunol; 2002 Jun; 3(6):529-35. PubMed ID: 12021778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity.
    Andoniou CE; van Dommelen SL; Voigt V; Andrews DM; Brizard G; Asselin-Paturel C; Delale T; Stacey KJ; Trinchieri G; Degli-Esposti MA
    Nat Immunol; 2005 Oct; 6(10):1011-9. PubMed ID: 16142239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of NKG2D signaling in inhibition of cytotoxic T-lymphocyte lysis by the Murine cytomegalovirus immunoevasin m152/gp40.
    Pinto AK; Jamieson AM; Raulet DH; Hill AB
    J Virol; 2007 Nov; 81(22):12564-71. PubMed ID: 17855532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein.
    Hasan M; Krmpotic A; Ruzsics Z; Bubic I; Lenac T; Halenius A; Loewendorf A; Messerle M; Hengel H; Jonjic S; Koszinowski UH
    J Virol; 2005 Mar; 79(5):2920-30. PubMed ID: 15709011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immunity regulates adaptive immune response: lessons learned from studying the interplay between NK and CD8+ T cells during MCMV infection.
    Mitrović M; Arapović J; Traven L; Krmpotić A; Jonjić S
    Med Microbiol Immunol; 2012 Nov; 201(4):487-95. PubMed ID: 22965169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction.
    Muntasell A; Vilches C; Angulo A; López-Botet M
    Eur J Immunol; 2013 May; 43(5):1133-41. PubMed ID: 23552990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.
    Rölle A; Mousavi-Jazi M; Eriksson M; Odeberg J; Söderberg-Nauclér C; Cosman D; Kärre K; Cerboni C
    J Immunol; 2003 Jul; 171(2):902-8. PubMed ID: 12847260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection.
    Muntasell A; Magri G; Pende D; Angulo A; López-Botet M
    Blood; 2010 Jun; 115(25):5170-9. PubMed ID: 20393128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting Edge: NKG2D Signaling Enhances NK Cell Responses but Alone Is Insufficient To Drive Expansion during Mouse Cytomegalovirus Infection.
    Nabekura T; Gotthardt D; Niizuma K; Trsan T; Jenus T; Jonjic S; Lanier LL
    J Immunol; 2017 Sep; 199(5):1567-1571. PubMed ID: 28760883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein.
    Welte SA; Sinzger C; Lutz SZ; Singh-Jasuja H; Sampaio KL; Eknigk U; Rammensee HG; Steinle A
    Eur J Immunol; 2003 Jan; 33(1):194-203. PubMed ID: 12594848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3K pathway during viral infection and transformation.
    Tokuyama M; Lorin C; Delebecque F; Jung H; Raulet DH; Coscoy L
    PLoS Pathog; 2011 Sep; 7(9):e1002265. PubMed ID: 21966273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.